- Home
- / PharmaTher Holdings
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PharmaTher Holdings financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.2
2024-10-29
Market Capitalization
$13.5 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Operating expense total | 255.0K | 1.8M | 3.2M | 3.4M | 3.1M | 1.6M |
| Depreciation and amortization | 1.0K | 1.0K | ||||
| EBITDA | (255.0K) | (1.8M) | (3.1M) | (3.4M) | (3.1M) | (1.6M) |
| EBIT | (255.0K) | 4.2M | (3.3M) | (6.0M) | (3.3M) | (1.6M) |
| Interest income | 207.0K | 187.0K | 60.0K | |||
| Pre tax profit | (282.0K) | 2.9M | (4.2M) | (6.4M) | (3.1M) | (1.5M) |
| Income tax expense | 225.0K | (225.0K) | ||||
| Net Income | (282.0K) | 2.7M | (4.0M) | (6.4M) | (3.1M) | (1.5M) |